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INTRODUCTION 
This thesis explores the pathological and clinical presentation 
of polycystic disease and their correlation with the findings available 
during intravenous urography. 
Polycystic disease of the kidneys (adult type) is a familiar and 
congenital pathological disorder transmitted through an autosomal domi¬ 
nant mode of inheritance. It is characterized by variable expressivity 
of the gene(s) with virtually 100% penetrance, if the patient survives 
into the ninth decade. Involvment is usually bilateral and pregres- 
sive; with the onset of symptons, the patient pursues an inexorable 
downhill course leading to uremia and death in the absence of operative 
intervention with renal transplantation. 
Polycys tic disease is characterized by irregularly shaped cysts 
of nephronic origin located diffusely throughout the cortical and medul¬ 
lary regions of the renal parenchyma with intervening areas of normal 
or minimally fibrotic renal tissue. There is a high incidence of asso¬ 
ciated cystic involvment of other viscera, principally the liver and 
spleen, cerebral aneurysm and erythrocythemia. (4, 17, 18, 20, 21, 31, 
42, 49, 60, 65, 72, 83) 
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PART ONE: PATHOLOGY 
GROSS PATHOLOGY 
On visual inspection, polycystic kidneys are almost always enlarged 
and may attain weights of seven or eight kilograms and measure as much as 
43 to 48 centimeters. (31) The degree of enlargement varies according 
to the number of nephrons evidencing cystic involvement and according to 
the volume of fluid accumulating within the cysts (29 ,60); generally, 
the degree of cystic change is related to the age of the patient (17, 31). 
Enlargement may proceed asynchronously leading to marked asymmetry of 
the two involved kidneys. 
Although disagreement exists about the existence of unilateral poly¬ 
cystic disease, involvement is usually bilateral. Bell (4) reported a 
unilateral incidence of 8%, by far the highest reported in the pathology 
literature; by contrast, Narins and Oppenheimer (50) contend that it is 
rare to encounter an adult with unilateral disease. In those cases of 
reported unilateral disease, the contralateral kidney has been described 
as either aplastic or hypoplastic. (4, 17, 29 , 50, 59 , 70) Two cases 
of polycystic disease in solitary kidneys have been reported and these 
underwent compensatory hypertrophy resulting in clinical courses similar 
to that of relatives with two kidneys. (3) 
Polycystic kidneys usually present as normally shaped kidneys al¬ 
though increased proportionally in size. The outer surface of the kidney 
is irregular and nodular, studded with translucent vesicles of varying 
size bulging from the capsular surface. The capsule of the kidney usually 
is unchanged although it may adhere firmly to the kidney surface and be 
difficult to strip. Examination of the cut surface reveals oval or spher¬ 
ical cysts filled with thin colorless fluid involving both the renal cortex 

and medulla. The cysts vary in size from the microscopic up to four to 
five centimeters. If there has been hemorrhage into a cyst, the fluid 
may be thickened and may shade in color from bright red to brown. Usually 
cysts are more numerous and more tightly packed in the cortex, often 
abutting one another and separated by only a single layer of epithelial 
cells. A medullary cyst may bulge into the renal pelvis. The normal 
architecture of the kidney is disturbed; papillae are often absent and 
the kidney is seldom divided into normal pyramids. (4, 11, 17, 29, 31, 60) 
The most frequent renal lesions associated with polycystic disease are 
hydronephrosis and pyonephrosis [usually secondary to compression of the 
ureter by a lower pole cyst], and pyelonephritis. (34) McNamara (47) in 
a series of twenty five post-mortem examinations reported a 57% incidence 
of pyelonephritis in patients with polycystic disease. Tumors and cal- 
culosis are less common associations. (31) Generally, the ureters, blad¬ 
der, and urethra are free of involvment. (29) 
HISTOPATHOLOGY 
The microscopic appearance of the .kidney is generally consonant 
with the degree of cystic involvment evident on gross inspection of the 
kidney, the mildest changes being found in those kidneys with a relatively 
normal gross appearance. (60) Destruction of nephrons may be due to 
progressive cystic dilatation of a component structure, compression of 
normal adjacent tissue by enlarging cysts leading to pressure atrophy 
and fibrosis, hemorrhage, and infection. (47, 60) 
In their classic microdissection studies of polycystic kidneys, 
Osthanondh and Potter (60) discovered that cysts may be found in any por¬ 
tion of the nephron and collecting duct, most commonly at the angle of the 
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loop of Henle and Bowman's space; however, any individual case may dis¬ 
play a preferential involvment for a given structure. As a rule, cysts 
are multipolar and communicate with the collecting system of the kidney. 
Glomerular cysts usually arise from a dilatation of Bowman's capsule. 
Glomerular tufts may be small and incompletely vascularized with capil¬ 
lary loops either separated by large amounts of hyalinized connective 
tissue or, in occasional specimens, scattered along the inner wall of 
the cyst. Individual or groups of tubules may dilate forming thin- 
walled cysts and demonstrate diffuse or saccular enlargment of the 
proximal tubule, the descending and ascending limbs of the loop of Henle, 
the distal tubule, or at the junction of the distal tubule and the col¬ 
lecting duct. (41, 60) Cysts of collecting tubules are generally larger 
than those of the~nephrons and are surrounded by a thick zone of com¬ 
pact connective tissue. (60) Cyst walls may be lined discontinuously 
with cuboidal or flattened epithelium; proximal tubular cysts often 
are lined by characteristic eosinophilic pyramidal cells with a recog¬ 
nizable brush border. (29) 
There is a fundamental disorder in the organization of the renal 
architectureDuring organogenesis, individual tubules of the metanephric 
blastema may divide asynchronously so that the architecture of minor 
calyces, papillae and pyramids may be quite different in different parts 
of the kidney. (60) Nephrons may attach irregularly to the collecting 
tubules resulting in a failure to form normal papillae and pyramids. 
Attachment of several nephrons to the end of a single collecting tubule 
result in pseudopapilla formation. Arcades may be absent when nephrons 
attach to collecting tubules proximal to the last generation. (60) Blood 
vessels are of irregular size and distribution; interlobular arteries 
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frequently course beneath cyst walls composed of a single layer of 
epithelium leading to considerable hemorrhage with arterial rupture. (31) 
Arterioles may be involved by a sclerosing process giving rise to 
thickened walls and narrowed lumens. (31, 60) Nerve trunks often de¬ 
monstrate increased prominence. 
ASSOCIATED ABNORMALITIES 
The most commonly associated abnormality of polycystic kidney 
disease is polycystic liver disease. The reported association in the 
pathology literature varies from 16% (17) to 73% (83); the most com¬ 
monly accepted figure, however, is 33%. (14, 29, 65) Conversely, the 
association of polycystic involvment of the kidneys in patients with a 
primary diagnosis of polycystic liver disease is 50%. (14) Other cystic 
disorders associated with polycystic kidney disease are polycystic pan¬ 
creas, approximately 10% (29, 65), spleen, 2% to 5% (29, 65), and rarely, 
thyroid, ovary, endometrium, seminal vesicle, epididymus, esophagus, and 
cerebellum. (17, 29, 31) 
Significant clinically, there is a high association (15%) of 
aneurysm of the basal arteries of the brain with polycystic disease; 
the anterior half of the circle of Willis is the most frequent location 
of these aneurysms. (17, 29) Conversely, 3.5% of patients with intra¬ 
cranial aneurysm have associated polycystic disease. 
ETIOLOGY AND PATHOGENESIS 
Numerous theories have been advanced describing the pathogenesis 
of polycystic disease; none is adequate to explain fully the disease and 
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its associations. They may be divided into four general classes: the 
embryogenic; the metabolic; the neoplastic; and, the inflammatory. The 
embryogenic theories of Hildebrand (30) and Kampmeier (38, 48) have gained 
the most wide-spread acceptance. Hildebrand postulates that the condi¬ 
tion arises from a derangement in the union of the dual anlagen of the 
developing kidney; a failure of the union of the ureteric bud with the 
metanephric blastema deprives the primitive nephrons of an organizing 
influence giving rise to disturbed renal architecture and cyst formation. 
Kampmeier proposes that the disease has its origins in a disturbance in 
the normal processes of division and involution; thus, there is a failure 
of involution of the first generation of nephrons to differentiate in 
the metanephrons with eventual cystic degeneration. Potter (60) echoes 
Hildebrand suggesting that there is a failure of coordination in the 
patterns of division of the collecting tubules, deriving from the ureteric 
bud, and the nephrons and connective tissue, deriving from the metanephric 
blastema. The metabolic theories (18, 61, 72) adduce a toxic metabolite 
from experimental preparations with cystic disease induced by exogenously 
administered agents. Additional support for this theory is lacking in 
that, as yet, there have been no reported cases of polycystic transforma¬ 
tion of a kidney transplanted into a patient suffering from polycystic 
disease of his own kidneys. [There has been a considerable transplant 
experience in polycystic disease; the last three reports of the Human 
Transplant Registry (76, 77, 78) indicate that approximately 5% of renal 
transplants performed annually have been for the treatment of polycystic 
disease.] The neoplastic theories (17, 33) attribute the disease to 
hamartomas or cystic adenomas of the renal substance. Finally, the in¬ 
flammatory hypotheses attribute cyst formation to a variety of insults to 

the kidney: papillitis (31), arterial ruptures into the substance of 
the kidney (35), and tubular occlusion resulting in multiple retention 
cysts (17). 
7 
INCIDENCE 
Estimates of the incidence of polycystic disease vary widely be¬ 
tween clinical and autopsy data, but indicate, that there is widespread 
failure to recognize the disease ante-mortem. [Table I] Men and women 
are equally involved, the disease demonstrating no sex predominance.[Table 2] 
TABLE 1: CLINICAL AND AUTOPSY INCIDENCE OF POLYCYSTIC 
DISEASE OF THE KIDNEYS 
SURVEY 
1. Mt. Sinai Hospital, 
New York City 
2. Mayo Clinic 
3. Jewish Hospital, 
Brooklyn, N.Y. 
4. London Hospital, 
London, England 
5. University of 
Minnesota 
6. Nauman 
7. Cleveland Clinic 
8. Dalgaard Denmark (17) 
9. Bell (4) 
10. Simon and Thompson (22) 
after Higgins (31) 
DIAGNOSIS 
ON CLINICAL DIAGNOSIS 
CRITERIA BY AUTOPSY 
1:3,666 1: 428 
1:3,524 1:1 ,019 
1: 158 
1:4,800 
1: 509 
1: 650 
1:4,000 
1: 773 
1: 351 
1:2,438 1: 323 
Symptans of the "adult form" of the disease may appear at any age; how¬ 
ever, it presents most frequently in the fourth or fifth decades of life. 
[Table 3] 
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TABLE 2: CLINICAL INCIDENCE OF POLYCYSTIC DISEASE IN MEN 
AND WOMEN 
NUMBER NUMBER 
OF MEN OF WOMEN TOTAL 
Dalgaard (17) 157 193 350 
Simon and Thompson (72) 203 163 366 
Rail and Odell (65) 94 113 207 
TABLE 3: AGE OF CLINICAL INCIDENCE OF POLYCYSTIC DISEASE 
AGE (in years) DALGAARD (17) SIMON AND RALL AND 
AT DIAGNOSIS MEN WOMEN THOMPSON (72) ODELL (65) 
0-9 2.5% 3% 
10-19 0.6% 0.5% 
(15-19 years) 1.1 1 
20-29 4.4 6.8 8.7 9 
30-39 22.9 23.0 22.4 34 
40-49 29.9 27.9 34.2 27 
50-59 25.4 24.8 22.4 20 
60-69 11.5 11.4 6.8 6 [ greater 
70-79 3,8 5.2 1.9 than 60 
80-84 1.9 yrs. of age] 
PART TWO: CLINICAL FEATURES 
CLINICAL PRESENATION 
The diagnosis of polycystic disease is a challenge to the clinician. 
The clinical picture is often misleading depending upon the stage at which 
the patient presents for diagnosis; none of the signs or symptoms is patho¬ 
gnomonic. 
The onset of the disease is usually insidious; the patient may be 
unaware until routine physical examination and laboratory analysis dis¬ 
close renal enlargement, hypertension, proteinuria, microscopic hematuria, 
or evidence of asymptomatic urinary tract infection. (17) Simon and 
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Thompson (72) report that 133 of 366 patients in their series had no 
symptons referable to polycystic disease at the time of diagnosis. 
The clinical history is invaluable in the diagnosis. Polycystic 
kidney disease is an autosomal dominant hereditary disease with variable 
penetrance and expressivity. (17, 18, 20, 62, 83) There is virtually 
100% penetrance if the patient survives into the ninth decade of life. 
[vide supra] Despite this, reports of a positive family history range 
from 18%, in a series of 366 by Simon and Thompson (72), to 36%, in a 
series of 94 cases compiled by Higgins (31). The classic presentation 
is of a middle-aged person with a positive family history and symptons 
referable to early renal failure. (63) [ Table 4] As in the case of 
most classic presentations, this constellation is encountered infrequently. 
TABLE 4: PER CENT INCIDENCE OF 
CYSTIC KIDNEY DISEASE 
CLASSIC FINDINGS IN POLY- 
Rail and Simon and Daalgard Higgins Ward, Draper, 
Odell 
(65) 
Thompson 
(72) 
(17) (31) and Lavengood 
(83) 
Cases 
FINDING 
207 366 350 94 53 
Family history 
(positive) 34 18 — 36 32 
Gross Hematuria 48 31 45 41 47 
Abdominal pain 28 44 59 64 47 
Hypertension 
Palpable kidneys 
73 55 46 73 62 
(one or both) 
Elevated blood 
72 78 61 80 73 
urea nitrogen 36 44 44 70 45 
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Pain is the cardinal presenting symptom for which a patient seeks 
medical assistance. (17, 31, 65, 72, 83) Most commonly, he complains of 
a dull nagging ache or pressure in the flank. The pain is usually uni¬ 
lateral, may be intermittent or continuous, and may be so persistent and 
severe as to be disabling. (17, 31, 65, 72, 83) The pain may result from 
the excessive weight of the kidney producing tension on the renal pedicle, 
hemorrhage within a cyst, or the mechanical pressure of expanding cysts on 
adjacent organs. (72) The reported incidence of flank or abdominal pain 
ranges from 28% (65) to 64% (31). [Table 4] Acute renal colic is unusual, 
but may occur with the passage of a clot down the ureter. (72) Loin 
pain radiating to the back, chest, epigastrium, or groin may also be en¬ 
countered. Complaints of pain usually occur early in the course of the 
disease. 
Gross hematuria is the second most common complaint. [Table 4] 
Hematuria is usually self-limited, of short duration, episodic, and sel¬ 
dom heavy enough to cause exsanguination. It is precipitated in most 
instances by trauma or unusual physical exertion. (17, 31, 72, 83) If 
persistent, it may be associated with anemia. (83) Bell (4) and Simon 
Thompson (72) assert that over the course of their disease, between one 
third and one half of patients will develop hematuria. Appearance of 
gross bleeding shows no sex predominance and usually appears in the mid¬ 
dle of the disease’s course. (17) 
There is an unusually high incidence of urinary tract infection in 
polycystic disease suggestive of an increased susceptibility to bacterial 
invasion. (17) [vide infra] The reported incidence of symptomatic uri¬ 
nary tract infection: frequency, dysuria, fever, chills; ranges from 21% 
(72) to 69% (31). 

In Rail and Odell's series (65), 20% of patients presented to 
renal clinic following the discovery of renomegaly, either by themselves 
or the referring physician. On physical examination, renal enlargement 
was found bilaterally in 51% to 60% of cases and unilaterally in 13% to 
25% of cases, with an unexplained predominance of left sided enlargement 
with unilateral physical findings. (17, 31, 65, 72, 83) Occasionally, 
enlargement may occur to the point of causing visible distention of the 
abdominal wall and an increase in the circumference of the abdomen.(17) 
Hypertension is a frequent physical finding during the course of 
polycystic disease and not infrequently is the first sign detected in 
the disorder. Rail and Odell (65) found that the initial finding of 
hypertension led to the diagnosis in 16% of their polycystic population; 
furthermore, they found a 35% incidence of hypertension during the initial 
visit for the evaluation of the disease. Disparity in the time course at 
which a patient presents for diagnosis may account for the variations in 
the incidence of hypertension [35% (65, 72) to 62% (83)] during that 
initial visit. 
CLINICAL COURSE AND LABORATORY DATA 
Cysts present at birth (20, 31, 41, 60, 62) remain asymptomatic 
through the patient's early decades allowing him to pursue a normal life. 
Symptoms may appear as early as the second decade (17), but these are 
generally well tolerated until the fourth or fifth decade; as the cysts 
enlarge and renal function deteriorates the patient seeks medical atten¬ 
tion. (17, 31, 65, 72, 83) [Table 3] When the disease first manifests 
itself in later life, it pursues a more virulent downhill course, with 
death from hypertension and its sequelae or uremia within a few years. 
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(17, 31, 83) Survival following the onset of symptoms is usually less 
than ten years. (27) Patients with the disease enjoy a shorter life ex¬ 
pectancy than the general population. Simon and Thompson (72) compared 
the five and ten year survival of normal and polycystic populations. They 
found that the unwolved group, at age 44 years, had a five year survival 
rate of 96% and a ten year survival of 90.5%; this compared sharply with a 
survival rate of 56% and 38%, respectively, in the polycystic group. Post¬ 
diagnosis, eleven of their 366 cases survived more than twenty years, and 
Dalgaard (17) reported one thirty five year survivor. 
Many patients will remain asymptomatic into the seventh and eighth 
decades, and polycystic disease may be an incidental finding at autopsy. 
(4, 17, 31) In their post-mortem series of fifty eight patients with 
polycystic kidney disease and concomitant polycystic involvement of the 
liver, Hatfield and Pfister (27) found wide discrepancies between the group 
of patients who were asymptomatic at the time of death and the symptomatic 
group and question whether polycystic kidney disease is an unified diag¬ 
nostic estity. To summarize their findings: the average age at the time 
of death for the asymptomatic group was 73.0 years. The combined weight 
of their kidneys was 512 grams [normal: 125 to 170 grams in males; 115 to 
155 grams in females]. One fifth of these patients had at least one cyst 
greater than three centimeters. The group of patients who were sympto¬ 
matic ante-mortem averaged 51.8 years at the time of death. Their kidneys 
weighed 930 grams, and one half had at least one cyst larger than three 
centimeters. Both groups had an equal incidence of asymmetric renal en¬ 
largement. Rather than representing two distinct entities, these findings 
may also be interpreted as consistent with a hereditary disease of variable 
expressivity. 
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Polycystic kidneys may be involved by any of the acquired renal 
diseases. Inflammatory complications include such entities as pyelitis, 
pyelonephritis, and paranephritis. (17) The reported incidence of uri¬ 
nary tract infection may approach 65% with problems of recurrence in 
approximately 11% of cases. (17, 31, 65, 72, 83) [Table 4] The most 
commonly associated pathogens are E. Coli, P. vulgaris, Staph, albus, and 
Str. faecalis. (31) Mac Namara (47) examined the kidneys of twenty three 
patients with polycystic disease who came to necropsy for evidence of 
pyelonephritis. He found evidence of infection in the kidneys in thir¬ 
teen patients [57%], eight of whom [35%] had evidence of extensive infec¬ 
tion involving more than 50% of the kidney. Of these thirteen patients, 
only four were expected to have pyelonephritis ante-mortem. Malignancy 
is rarely associated with polycystic disease; there are fewer than twenty 
five cases reported including one case each of intracystic papilloma, 
fibrosarcoma, and angiomyosarcoma. (2, 8, 9, 10, 13, 15, 17, 28, 32, 36, 
43, 46, 50, 51, 64, 67, 71, 75, 79, 81) The problems of diagnosis in a 
kidney with an already deformed gross structure are obvious, and, in most 
cases, malignancy was not expected prior to surgical exploration or necropsy. 
The relentless cystic conversion of the kidneys leads to progressive 
renal insufficiency in the majority of cases. (17, 31, 72) Dalgaard (17) 
noted that within a family, the pattern of deterioration had a certain 
uniformity. Early in the clinical course, urinalysis, renal function tests 
and serum chemistries are of little value in the assessment of the disease 
(31); cystic nephrons retain their function and contribute to the functional 
capacity of the kidney. (11, 17, 41) Normotensive patients with uremia 
may remain stable for many years, but with the supervention of uncontrolled 
hypertension, the patient pursues a rapid and inexorable downhill course. (27) 
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Rail and Odell (65) reported that following the onset of azotemia [BUN•> 
40 mg/100ml.] the average life expectancy was 2.2 years. 
Serial examination of patients demonstrate that four fifths will 
develop hypertension during their clinical course (31, 65, 72); nearly 
all will be hypertensive pre-terminally. (83) Hypertension in combina¬ 
tion with cerebral aneurysm or renal failure augurs an ominous turn in 
events; these patients have an average life expectancy fifteen years shorter 
than normotensive patients with aneurysm or azotemia. (27) 
Despite uremia and recurrent hematuria, polycystic patients are 
able to maintain hemoglobin levels in excess of 11 gm/100 ml. (31, 65, 72) 
Polycystic patients who come to dialysis tolerate the procedure better 
than other uremic patients; they require fewer transfusions to maintain 
their hematocrits. (42) In rare instances, polycystic disease has been 
associated with frank polycythemia vera. (12, 24, 25, 37, 73) The rela¬ 
tive erythrocytosis during dialysis (42) and frank pdycythemia (73) are 
both corrected by nephrectomy. No studies, to date, have been published 
correlating levels of erythropoietin with erythrocytosis in these patients. 
The association suggests that a combination of uremia and high or normal 
levels of hemoglobin may lead to an unsuspected diagnosis of polycystic 
disease in the patient with renal failure. 
Leading causes of death in polycystic disease are uremia, myocar¬ 
dial infarction, cerebro-vascular accident and cardiac decompensation 
secondary to hypertensive cardiovascular disease. (72) [Table 5] 
TABLE 5: LEADING CAUSES OF DEATH IN POLYCYSTIC KIDNEY DISEASE 
Terminal Event Dalgaard (17) Rail and Odell (65) Higgins (31) 
Uremia 59% 20% 66% 
Cardiac disease 6 13 — - 
Cerebral hemorrhage 13 9 
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With the advent of hemodialysis, renal transplantation and neph¬ 
rectomy, the natural history of polycystic disease has been altered^, im¬ 
proving the long term prognosis. (1, 5, 42, 63, 69) Lazarus and his 
co-workers (42) have reported considerable success in the control of hyper¬ 
tension with dialysis. All their patients suffered from symptomatic 
uremia at the time at which dialysis was instituted; they reported no 
unusual complications from the procedure. Because of the relative ery- 
throcytosis of polycystics [vide supra] they discourage routine nephrec¬ 
tomy except in cases with uncontrolled hematuria or life threatening sepsis. 
The results of renal transplantation were.also encouraging provided that 
transplant recipents were first stabilized on hemodialysis and that the 
graft survived for at least six months. Pre-transplant nephrectomy has 
been advised to obviate the mechanical problems during surgery from grossly 
enlarged kidneys, for control of upper urinary tract infection, hyperten¬ 
sion and vesico-ureteral reflux. (68) 
RADIOLOGY 
Radiographic diagnosis of polycystic disease becomes feasible with 
the progression of the disease to gross involvement. During the early 
course of the disease, radiologic changes are minimal and may pass unde¬ 
tected. Diagnostic accuracy is increased and earlier detection of changes 
made possible through the use of special study techniques such as retro¬ 
grade pyelography (31, 72), infusion pyelography (27, 68, 83), nephro¬ 
tomography (17, 23, 26, 33), and renal angiography (7, 12, 16, 20, 22, 49) 
On the plain film of the abdomen, large irregular renal outlines 
are suggestive of polycystic involvement. The kidneys have an embossed 

outline and are usually longer than fourteen centimeters. When the kid¬ 
neys are not visualized on the plain film, displaced loops of bowel are 
suggestive of enlargement. (7, 17, 21, 22, 40) With advancing age of 
the patient, the degree of enlargement increases. Thus, enlargement is 
found in 11% of patients at age 35 years, 50% at age 50, and 74% at age 
75. (17) 
Visualization of the renal parenchyma and collecting system with 
the use of contrast materials allows further delineation of polycystic 
involvement. [Figure 1] During the latent phase of the disease small 
radiolucencies which correspond to areas of cystic involvement produce a 
non-homogenous nephrogram; in the presence of normal renal function, the 
nephrogram may be assessed during the first three minutes of urography. (26) 
During nephrotomography (12, 23, 33) or infusion tomography (27, 83) [in 
patients with BUN > 40 mg.%] visualization of cysts as well-demarcated, 
thin-walled, sharp radiolucencies in the midst of normally functioning 
areas of parenchyma give rise to a characteristic moth-eaten appearance. 
The renal calyces appear elongated and crescentic. Impinged upon by cysts 
of varying sizes, they are often described as "spidery". (7, 17, 20, 31, 
72, 83) This must be differentiated from the "spider-leg pelvis", a 
normal variant. (21) Because of intervening cysts, the renal parenchyma 
appears thickened (21); measuring greater than three centimeters from the 
most laterally projecting calyx to the margin of the kidney [normal: 2.7 cm. 
(7, 17) The longitudinal axis of the kidney shifts from its normal posi¬ 
tion parallel to the spine. (7, 17) Multiple cystic impressions impinge 
upon the renal pelvis which may be shifted laterally due to the enlarge¬ 
ment of parenchyma medial to it. (7) The pelvic ampulla assumes a horn 
shape; since this is also a normal variant this sign is useful only as 
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Fig. 1. Intravenous Pyelographic Findings in Adult Polycystic 
Disease of the Kidneys. 
A. Right Kidney: Urogram demonstrates elongated spidery calyces, sculpted 
by numerous cysts. Large lower pole cyst extends from L-3 to iliac crest. 
The longitudinal axis of kidney is displaced shifted nearly parallel to 
spine. 

1 B. Detail of right kidney; Lateral margin and most laterally projecting 
calyx: Demonstrating attenuation of calyceal system. 
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1 C. Left kidney: Urogram demonstrates knobby, irregular renal outline. 
The calyceal system is sculpted by numerous cysts. The longitudinal 
axis of the kideny is shifted parallel to spine. 

20 
1 D. Detail of left kidney; lateral margin of kidney and most laterally 
projecting calyx: The calyx is indented by a cystic impression. 
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further confirmatory evidence in the diagnosis. (7) Lowman and Haber (44) 
recommend simultaneous hepatonephrotomograph in order to detect any co¬ 
existing cystic disorder of the liver. 
Because of the risk of ascending infection, instrumentation of 
the upper urinary tract must be approached with caution. (17) Retro¬ 
grade pyelography provides more complete visualization of the collecting 
system and may increase the diagnostic accuracy in the case of inadequate 
intravenous urography. (72) The findings on retrograde examination are 
similar to those described above. (17, 31, 49, 72) 
Angiography is the most discriminating tool in the radiographic 
analysis of polycystic kidneys. (7, 16, 22, 49) During the nephrogenic 
phase, the kidneys assume the characteristic moth-eaten appearance. (7, 20, 
21, 22, 49) The arterial phase may reveal deformed, partially atrophic 
vessels, with displacement of the interlobular and segmental arteries by 
large cystic masses. (88) The volume of the renal parenchyma may be 
estimated from the relative size of the renal outline and its arterial 
tree; a small arterial system supplying a large kidney mass indicates a 
significant loss of parenchyma. (49) 
In a series of twenty three patients reviewed by Hatfield and 
Pfister (27), intravenous pyelography proved diagnostic of polycystic 
disease in eight patients, suggestive of the disease, but not diagnostic 
in another fourteen and interpreted as within the limits of normal in one 
case. Unilateral changes were present in seven patients all of whom 
evidenced bilateral disease at autopsy. In eleven cases where retrograde 
pyelography was performed, the examinations were diagnostic in three. They 
were encouraged by the results of infusion tomography, obtaining the 
diagnosis in three cases studied in this way, and recommended it as the 
study of choice for evaluation of the suspected case of polycystic disease. 
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TABLE 6: RADIOGRAPHIC FINDINGS IN POLYCYSTIC KIDNEY DISEASE 
I. On Plain Film of the Abdomen 
A. Large renal outlines: length greater than 14 cm.; 
with possible displacement of bowel. 
B. Embossed outline 
II. Intravenous Pyelogram 
A. Parenchymal thickening: greater than 3 cm. 
B. Elongation of the renal pelvis: greater than 9 cm. 
C. Elongation of calyces. 
D. Crescentic, spidery calyces. 
■I E. Multiple impressions of cysts in the renal pelvis. 
F. Lateral displacement of the pelvis. 
G. Longitudinal axis of the kidney parallel to the spine. 
III. Nephrotomography 
A. Moth-eaten appearance during nephrogram phase. 
B. Well circumscribed radiolucencies surrounded by nor¬ 
mally opacified parenchyma. 
IV. Renal Angiography 
A. Moth-eaten appearance during nephrogenic phase. 
B. Well circumscribed radiolucencies surrounded by nor¬ 
mally opacified parenchyma. 
C. Deformed, partially atrophic vessels. 
D. Displacement of interlobular and segmental arteries. 
Ultrasound offers the possibility of early diagnosis, before the 
characteristic roentogenographic changes appear on intravenous urography. 
Lufkin, et. al. (45) studies sixty four patients in a kindred for evidence 
of polycystic disease. Thirty one patients displayed sonographic evidence 
of the disease; only fifteen of these evidenced changes on intravenous pye¬ 
lography. 
DIFFERENTIAL DIAGNOSIS 
The major problem in the differential diagnosis of polycystic 
disease is the distinction of the condition from renal neoplasm. Presen¬ 
tation of a patient with non-specific symptoms referable to the kidney, 
renal enlargement on plain film of the abdomen or intravenous urography, 
and, perhaps, some compromise of renal function immediately raise the 
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specter of renal neoplasm. The most useful reontgenographic technique 
used to distinguish cystic enlargement from the malignant, is renal angio¬ 
graphy. (7, 12, 49) During the arterial phase of an angiogram, a neo¬ 
plasm demonstrates a confluence of irregular, small vessels or a puddling 
of contrast material in the region of the lesion, the "tumor blush"; dur¬ 
ing the nephrogenic phase, a malignant lesion has a radiographic density 
equal to or greater than that of the surrounding renal parenchyma, and 
may show areas of necrosis. (12) A cystic lesion demonstrates an avas¬ 
cular space occupying lesion during the arterial phase, and one or more 
round or ovoid lucencies which are well marginated by the surrounding nor¬ 
mal parenchyma during the nephrogenic phase. (12) Ultrasound has also 
been used successfully to differentiate cystic from solid space occupying 
lesions within the kidney. (45) 
Because of the prognostic implications and the need for accurate 
counseling, polycystic disease must be distinguished from other cystic 
disorders of the kidney. [Table 7] Cystosis may cause renal enlargement 
detectable on physical examination, and a radiographic picture similar to 
polycystic disease. (17) A diagnosis of retention cysts of the kidney 
carries little promise of progressive renal functional impairment. Simple 
cysts may be single, multiple, multilocular or hemorrhagic. A kidney with 
multiple simple cysts may be differentiated from polycystic disease be¬ 
cause it is usually unilateral, causes less destruction of the renal paren¬ 
chyma, and is non-hereditary. (17, 74) On physical examination, a kidney 
with multiple cysts may be palpably enlarged, and, radiologically the in¬ 
volved kidney may resemble the polycystic kidney. Pyelogertic (peripelvic) 
cysts are usually adjacent to the renal pelvis, communicating directly 
through a calyx. A parapelvic cyst is adjacent to the pelvis, but lacks 
direct communication. These two entities may cause lateral deviation of 

24 
the renal pelvis, one of the roentgenographic signs of polycystic disease. 
Kidney cysts may also arise secondary to the variety of pathologic processes 
of the kidney such as calculosis, hypernephroma, tuberculosis, pyelonephri¬ 
tis, hematoma, and echinococcus. (17) There is some debate in the litera¬ 
ture about medullary sponge kidney as an entity distinct from polycystic 
disease. (56) 
Other pathologic processes which must be distinguished from polycystic 
disease are chronic glomerulonephritis, chronic glomerulonephritis with 
associated hypertension, pyonephrosis, bilateral hydronephrosis, nephropto¬ 
sis, and tumors and cysts in adjacent organs. (17) Radiographically en¬ 
larged, poorly functioning kidneys must also be distinguished from renal 
amyloidosis, leukemic infiltration of the kidney, multiple myeloma, and 
the collagen vasculidides. 
TABLE 7: DIFFERENTIAL DIAGNOSIS OF CYSTIC LESIONS OF THE 
KIDNEYS 
1. Retention or inflammatory cysts 
2. Simple cyst 
a. Single cyst 
b. Multiple cyst 
c. Multilocular cyst 
d. Hemorrhagic cyst 
- 
3. Peripelvic cyst 
4. Parapelvic cyst 
5. Pathologic cyst 
a. Calculosis 
b. Hypernephroma 
c. Echinococcus 
d. Other 
after Dalgaard (17) 
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TABLE 8: DIFFERENTIAL DIAGNOSIS OF BILATERAL RENAL ENLARGEMENT 
1. Polycystic disease 
2. Renal neoplasm 
3. Chronic glomerulonephritis 
4. Bilateral hydronephrosis, pyonephrosis 
5. Cystosis 
6. Renal amyloidosis 
7. Leukemic infiltration 
8. Multiple myeloma 
9. Collagen vascular disease 
PART THREE: CLINICAL AND RADIOLOGICAL CORRELATIONS AND THE SIGNIFICANCE 
OF THE INTRAVENOUS UROGRAM 
MATERIALS AND METHODS 
Recently, Lalli and Poirier (40) contended that serial intravenous 
pyelography constituted a useful tool in the evaluation of the progression 
of polycystic disease and the prognostication of its clinical course. They 
based their conclusions on a sample of twenty patients drawn from the Cleve¬ 
land Clinic's pool of 509 cases. [Table 9] From this data, they concluded 
TABLE 9: RESULTS OF SERIAL PYELOGRAPHY IN TWENTY PATIENTS WITH 
POLYCYSTIC DISEASE OF THE KIDNEYS Observation 
No. of Family Hyper- Hema- Period (yr.) 
Patients History Uremia tension Death turia Aver. Range 
Enlarged 9 4 6 8 2 4 11 2-21 
Minimal 
Enlargement 8 4 3 5 0 5 5.1 2-11 
Not Enlarged 3 2 2 2 0 1 13 8-18 
Total 20 10 11 15 2 10 9.7 2-21 
after Lalli and Poirier (40) 
that correlations were made between advancing renal size and the presence 
of clinical complications, and that an observed increase in renal size was 
in fact correlated with the severity of the disease and could be used as an 
indicator of probable shortened life expectancy. 
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Chi square analysis of the data, however, leaves a less definitive 
impression than this conclusion would imply. Because of the sample size, 
the data from the minimally enlarged and unenlarged groups were pooled 
for interpretation. Lalli's data are not statistically significant. In 
terms of the sequelae of polycystic disease, uremia [p < 0.50] and hyper¬ 
tension [p < 0.20], the data do not present a valid statement of prognosis. 
The increase of mortality, although not significant [p < 0.10] is sugges¬ 
tive and merits further investigation of the experimental hypothesis. 
Intravenous pyelography is a relatively non-invasive, benign pro¬ 
cedure. Accurate prognosis on the basis of IVP would permit a more thorough 
orchestration of the patient's clinical management, allowing the selec¬ 
tion of a compatible kidney donor while the patient is yet able to main¬ 
tain himself on his own diminishing renal function and before multiple 
transfusions during dialysis have sensitized him to possible donor anti¬ 
gens. Timely use of transplant and nephrectomy [vide supra] would have 
a salutory effect on the natural history of the disease process. (5, 42, 
68, 69, 77, 78) 
The experimental population was derived from a review of the records 
of ninety six cases of polycystic disease at the Yale-New Haven Hospital, 
the West Haven Veteran's Administration Hospital, the Hospital of St. Raphael, 
New Haven, Connecticut, and the Waterbury Hospital, Waterbury, Connecticut. 
Intravenous pyelograms were available on thirty patients, eleven of 
whom had undergone serial examinations which were still on file. The 
eleven patients had a total of thirty urograms which were examined inde¬ 
pendently by the author and six staff radiologists at the Yale-New Haven 
Hospital. The radiologists were asked to evaluate the parameters of 
renal length and width, calyceal length and the thickness of the renal 
parenchyma from the most lateral projecting calyx to the lateral margin 
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of the kidney. [Figure 2] Names of the patients were masked, and the 
examinations randomized in order to prevent comparison with a patient's 
previous pyelogram. Films for a given examination were reviewed indepen¬ 
dently by the six radiologists and a statistical mean drawn. These results 
were used as a standard of accuracy to gauge the reliability of the author's 
assessment of the material reviewed independently. Normal values were 
taken from literature controls. (54, 55, 80) [See Appendix A] No con¬ 
trols for the length of the calyceal system were available. A control 
group was drawn from seventy five consecutive cases performed at the Yale- 
New Haven Hospital from February 1 to April 23, 1974, and interpreted to 
be within the range of normal by the attending staff radiologist. [See 
Appendix B] 
DISCUSSION 
In the evaluation of clinical history, the cohort of thirty patients 
was divided into groups according to the presence or absence of urinary 
tract infection, uremia, and hypertension. The mean lengths of the kidneys 
in these groups on intravenous urography were compaired using a one tailed 
"t" test; a correlation was considered statistically significant if p < 0.05. 
Analysis of data indicated a statistically significant correlation between 
an increased kidney length and an increased incidence of infection docu¬ 
mented by culture of the urine. The longer kidney was measured and the 
mean length of the kidneys in patients with infection was 18.6-2.2 cm. and 
without infection, 16.3-2.8 cm. [p < 0.025] Thus, not only is there an 
increased incidence of infection among patients with polycystic disease (79), 
but that incidence increases as the kidneys enlarge. Similar data in patients 
with uremia, while not statistically significant were suggestive of a pos- 
■ 
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Fig. 2: Polycystic Kidney Disease — Adult Type; Assessment of Renal 
Parameters. (See text) L= Length, W = Width, C = length of 
calyceal system, P = width of renal parenchyma measured from 
the lateral margin of the kidney to the most laterally pro¬ 
jecting calyx. 
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sible correlation between kidney length and uremia; the mean length of 
kidneys in uremic patients was 19.5-3.0 cm. and in non-uremic patients 
17.2- 2.9 cm. [p < 0.10] There was no significant difference demon¬ 
strated with hypertension; the mean length of the kidneys in hypertensive 
patients was 17.9-3.1 cm. and in normotensive patients 17.2-2.6 cm.[p < 0.30] 
The data for infection may be viewed from another perspective. [Table 10] 
TABLE 10: CORRELATION OF KIDNEY LENGTH AND URINARY TRACT 
INFECTION 
No. of patients No. of patients 
Kidney length (cm.) with infection without infection Total 
<15 2 6 8 
15 to 18 5 4 9 
>18 8 5 13 
Total 15 15 30 
The group of eleven patients for whom serial examinations were 
available was broken down into groups according to the interval develop¬ 
ment of urinary tract infection and uremia, and the eventual development 
of renal failure [the institution of hemodialysis]. Thus, a patient mani¬ 
festing hypertension at the time of initial urography was eliminated from 
consideration in the cohort that developed elevated blood pressures. A 
one-tailed "tn test with a value p ^.0.05 was considered significant. The 
size on the population developing interval infection and uremia [one case 
each] precluded meaningful analysis. The analysis of increasing kidney 
size and hypertension was not statistically significant, a finding consis¬ 
tent with Lalli's data (40); the interval change in patients developing 
hypertension was 1.0-2.3 cm. and in those remaining normotensive 3.0-2.8 cm. 
[p _< 0.30] During the period of follow-up, two patients developed renal 
failure and began chronic hemodialysis. The interval change in patients 
going on to dialysis was 3.0-1.1 cm., and for the group not requiring dial- 
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ysis 1.8-2.5 cm. [p < 0.025]. Because of the small population involved, 
this finding is not definitive, but merits further investigation. 
This study provides statistical confirmation of the clinical im¬ 
pression expressed in the literature that the collecting system of the 
kidneys is elongated in polycystic disease. (7, 17) The mean length of 
the calyceal system of the right kidney was 7.1-0.9 cm. for the series 
of seventy five uninvolved patients and 10.2-2.2 cm. for the series of 
thirty polycystic patients [p < 0.01] similarly, the calyces of the left 
side measured 7.2-0.9 cm. and 10.4-2.8 cm., respectively. [p < 0.01] 
[Appendices A, B] 
The measurements by the six staff radiologists were compared using 
a "t" test to analyze the data [Appendix A] . The precision of varian ce 
obtained was 1.1 cm. for the length of the kidney, 0.7 cm. for the width, 
0.7 cm. for parenchymal width, and 1.0 cm. for the length of the calyceal 
system. These measurements may be applied clinically as general state¬ 
ments on the precision of measurement of any one event. In this study, 
they provide a guide to the precision of the author’s. 
A retrospective study of hospital records is fraught with imponder¬ 
able variables. Of 96 cases on record at the four institutions involved 
in this study, urographic examinations were available on only 30. Due to 
problems of storage, X-rays are sent for reprocessing of silver salts 
after seven years at the Yale-New Haven Hospital and after only.four years 
at the Waterbury Hospital, if, during that period, the patient has not 
had further radiologic evaluation. Patients with polycystic disease may 
run a clinical course as long as thirty six years (17) during which time 
they may remain largely asymptomatic, not requiring medical assistance 
with consequent removal of early examinations from their records. Simple 
loss of films is a frustrating experience with which all clinicians are 
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familiar and which further compounds the problems of assembling a series 
such as this. Higgins (31) noted that during exacerbation of the disease 
patients develop hematuria pain and nitrogen retention which subside during 
periods of remission. It is during these periods of active disease, that 
the patient is most likely to present to the hospital or the hospital clinic 
for evaluation; thus, in many cases, the data available from hospital records 
may not be representative of the patients prevailing clinical status for 
much of his course. Assessment of the polycystic patient's data has been 
on the basis of "clinical gestalt," a combination of history, physical 
findings, and a laboratory evaluation which varies from physician to phy¬ 
sician. A prospective evaluation is needed comparing the efficacy of 
serial serum chemistry (BUN, creatinine), glomerular function (24-hour 
creatinine clearance), tubular function (PSP), urologic, and sonographic 
evaluations as a means of following a patient and determining the prognosis. 
A prospective study is now in progress at the Yale-New Haven Hospital in 
which polycystic patients and their families are being evaluated sonographically. 
SUMMARY 
Thirty patients with polycystic disease of the kidney were studied. 
A radiologic sign of increased length of the calyceal system in the kid¬ 
neys of patients with the disease over normal was described. Correlations 
of the clinical course of the disease and increased kidney length were 
made. There is a statistically significant correlation between the inci¬ 
dence of urinary tract infection and the increased length of the kidney. 
No such correlations were found for hypertension or uremia. Analysis of 
interval changes in kidney length in eleven patients with serial examina¬ 
tions, revealed a significant correlation between an interval change of 
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3.0 cm. on diagnostic urograms and the development of renal failure. The 
data did not support an association of the development of hypertension with 
increasing kidney length. 
Twenty nine intravenous pyelograms were examined by six staff radi¬ 
ologists of the Yale-New Haven Hospital. They were asked to measure the 
length of the calyceal system on each kidney on each examination. The pre¬ 
cisions of variance obtained when this was analyzed were:1 length = 1.1 cm. 
Width =0.7 cm.; parenchymal thickness =0.7 cm.; and, calyceal length = 
1.0 cm. These values may be used by the clinician as a guide to the pre¬ 
cision of measurement of a urogram by a radiologist on any one occasion. 
This study constitutes a necessary preamble to a study, now in 
progress, comparing the efficacy of intravenous pyelography and ultrasound 
in the investigation of polycystic disease. In order to evaluate the con¬ 
tributions available from ultrasonic investigation, it was necessary to 
define the limits of the currently accepted evaluative tool, intravenous 
urography. 
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APPENDIX A 
RADIOGRAPHIC MEASUREMENTS * OF NORMAL KIDNEYS 
Moell 1956 
(55) 
Moell 1961 
(54) 
Vourinen 
(80) 
MEN 
Right Kidney 
Length 
Width 
12.7 J 0.78 
6.3 - 0.49 
12.9 J 0.80 
6.2 - 0.45 
12.4 
6.2 
“f* 
t 1-02 
- 0.72 
Left Kidney 
Length 
Width 
13.2 | 0.82 
6.4 - 0.55 
13.2 | 0.79 
6.3 - 0.49 
12.7 
6.2 
i 1.12 
- 0.45 
WOMEN 
Right Kidney 
Length 
Width 
12.4 £ 0.66 
5.9 - 0.37 
12.3 | 0.79 
5.7 - 0.46 
12.0 
5.7 
X 1.08 
- 0.56 
Left Kidney 
Length 
Width 
12.8 | 0.77 
6.1 - 0.38 
12.6 0. 77 
5.9 - 0.42 
12.5 
6.2 
| 1.29 
- 0.61 
* all measurements in cm. ± 1 S. D. 
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RESULTS OF SERIAL PYELOGRAPHY IN ELEVEN PATIENTS AS READ BY SIX STAFF 
RADIOLOGISTS AT THE YALE-NEW HAVEN HOSPITAL 
LEFT KIDNEY* 
Patient Length 
Interval Change 
in Length Width 
Calyceal 
Length 
Parenchymal 
Width 
M. . B. 15. 2 
+ 
i 0.2 O 6. .4 
+ 
1. ,0 
14. 7 
T 
X 0.3 -0. 5/ 2/12 yr. •7. ,4 4- 0. ,4 
S. ,C. 18. 6 
i 
JL 0.4 9, .4 4_ 0. , 4 
18. 4 
i 
4* 0.2 -0. 2/ 3/12 yr. 9. , 8 
1 
+ 
0. .9 
C. , D. 15. 9 
T 
4- 0.5+ 6. , 6 4- 0. ,4 
16. 8 
i 
0.5+ 6. ,0 
T 
4- 0. ,3 
16. 6 4- 0.4 +0. 7/ 3i¥- 6. .8 
1 
4- 1. ,0 
18. 1 
i 
1.1 +1. 5/ 4io/12 ! yr. 7. ,0 
1 
0. ,4 
4. +2. 2/ 710/12 1 yr. 4- 
F. , D. 16. 7 
T 
1 0.5 9. ,4 
T 
1 0. , 6 
16. 5 
4“ 
1. 9 -0. 2/ 3/12 yr. 8. , 6 
T 
0. , 6 
G. , G. 14. 1** 1 8. ,0** 
15. 1** +1. 0/ 3J/12 yr. 7. .3** 
14. 8 0. 4 -0. 3/10^/12 yr. 8. ,0 - 0. .4 
4- +0. 7/13/12 yr. 4. 
G. J. 16. 3 
T 
1 0.7 O 9. ,5 
i 
1 0. ,9 
17. 8 
4“ 
t 0.3 +1. 9/ 17/12 yr. 9. , 6 
T 
.J. 0. .6 
17. 1 
T 
1.2 -1. 1/ 37/12 yr. 9. ,6 
*r 
0. ,5 
4. +0. 8/ 5/12 yr. 4- 
21. 0 
1 
1.0 +3. 9 : 1/12 yr. 10. ,6 
T 
0. ,9 
4- +4. 7/ 6/12 yr. 4- 
C. ,L. 18. 1 
1 
1 2.3 8. ,4 
1 
l 1, .0 
20. 9 
-r 
1 1. 3 +2. 8/ 712 yr. 8. ,5 0. , 6 
J. ,M. 20. 5 T 0.5 7 9. , 0** 
20. 4 + 4. 2.0 -0. 1/ 3/12 yr. 8. .4 
jr 
1 0. ,7 
A. ,M. 18. 7 » 1.0 9. ,2 4" 0. , 5 
18. 1 + 4. 0.1 -0. 6/ 4/12 yr. 9. ,0 
4" 
i 0. ,1 
G. ,S. 14. 9 1 0.3 8. ,0 4" 0. ,6 
15. 8 + I 0.3 +0. 9/ 712 yr. 8, .1 
+ 
1 0. .2 
M. , T. 17. 5 l 1.4 8. ,5 4* 0. , 6 
19. 1 + 2.1 +1. 6/ /12 yr. 7. .8 4- 0. ,3 
16. 1** -3. 0/ 1R/12 yr. 7. ,5** 
-1. 4/ i;/i2 yr. 
16. 7** +0. 6/ yr. 7. , 9** 
-0. 8/ 2/12 yr. 
9.7 
9.6 
12.3 
11.6 
9.5 
10.6 
9.4 
9.9 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
1.2 
0.6 
0.5 
0.9 
1.7 
0.4 
1.0 
0.5 
9.0 ±1.2 
10.3 - 0.9 
7.5** 
7.0** 
8.7 ± 0.7 
12.8 - 0.3 
13.1 ± 0.5 
12.6 ± 1.2 
12.4 - 1.4 
12.0 ± 0.8 
11.8 ± 0.3 
16.0 - 0.6 
11.7 - 3.9 
12.7 - 0.5 
13.3 - 0.6 
8.2 - 0.6 
8.9 - 1.1 
11.9 - 0.2 
11.7** 
11.0** 
2.5 
2.7 
3.0 
2.8 
2.6 
3.1 
+ 
+ 
+ 
+ 
+ 
+ 
0.6 
0.7 
0.2 
0.2 
1.8 
0.4 
3.3 ±0.8 
2.7 ± 1.1 
3.2 - 0.2 
3.0 - 0.0 
2.5** 
3.0 ± 0.7 
3.7 - 0.9 
2.3 x 0.6 
2.7 ± 0.5 
2.9 ± 0.6 
3.0 - 0.6 
2.5 ±0.5 
4.4 - 0.2 
2.6 - 1.4 
2.8 - 0.7 
4.5** 
2.3 - 0.5 
2.8 - 0.4 
2.8 - 0.2 
2.7** 
* all measurements in centimeters - 1 S.D. 
** read by only radiologist 
+ performed during same hospital admission; the first examination is 
an intravenous pyelogram, the second a tomogram 
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RIGHT KIDNEY* 
Patient Length 
Interval Change 
in Length Width 
Calyceal Parenchymal 
Length Width 
M.B. 15.5 J 0.8 6-7 7.2 - + 
8-7 5 
8.4 - 
0.3 8.7 i 
iS:f * 
13.0 i 
1.0 2.2 J 0.4 
14.0 ± 0.5 -1.5 2/12 yr. 0.2 0.2 2.2 - 
3‘1 + 
3.9 - 
0.4 
S.C. 19.4 J 0.7 A 0.3 0.7 0.6 
21.6 ± 0.5 +2,2/ 3/12 yr. 0.7 1.6 0.7 
C.D. 12.0+** 3.6** 
7.5** 0.3 12.4+** 2* 7 J 
10.7 ~ 0.4 -1.3/ 3 gr. 
+2.3/ 4^/12 yr. 
+0.6/ 7/12 yr. 
8.0 - 
7.7 Z 
1.3 6.0** 2.5 - 0.0 
13.0 - 0.9 0.2 6.7 - 0.7 2.9 - 0.3 
4* 4- 4- + 
F.D. 13.8 - 
15.8 - 
0.5 f) 8.5 - 
8.3 - 
0.3 7'9 + 8.4 - 
0.7 2.8 - 0.3 
1.3 +2.0/ 3/12 yr. 0.9 0.5 2.8 - 0.5 
G.G. 13.6** 1 6/7** 7.5** 3.0** 
14.5** +0.9/ 3^/12 yr. 6.2** 
6.7 - 
7.5** 
8.7 - 
2.5** 
2.4 - 15.4 ± 0.5 +0.9/10^/12 yr. 0.2 0.2 0.4 
4 +1.8/13/12 yr. 4. 
G. J. 16.5 ~ 1.8 o 9.7 - 
9.3 t 
0.5 9.5** 
11.3 J 
3.0 ± 0.1 
18.2 J 0.7 +1.7/ i;/12 yr. 
+0.8/ 3J /12 yr. 
1.1 0.4 2.9 ± 0.6 
19.0 - 3.2 9.1 - 0.7 13.4 1.0 3.2 ± 0.7 
19.4 - 0.2 
+2.5/ 57/12 yr. 
+0.4/ H/12 yr. IQ. 3 - 1.2 uJ 0.2 2.6 - 0.3 
+2.9/ 6/12 yr. 
3*° J C.L. 17.8 - 1.0 •J 7.8 l 0.3 10.1 J 
10.3 J 
11.2 J 
11-2 + 
13.3 - 
0.7 0.4 
24.9 l 0.9 +7.1/ 7/12 yr. 9.1 - 
8.9 + 
9.1 ^ 
9.5 - 
8*5 + 
0.8 2.1 3.2 | 
2.8 t 
0.6 
A.M. 20.3 J 
17.6 J 
3.2 A 0.5 0.4 1.5 
0.6 -2.7/ 712 yr. 0.3 1.5 3.8 - 
4.0 l 
3-4 l 
1.2 
J.M. 20.6 J 
20.2 - 
0.8 •J 0.0 1.0 1.3 
2.0 -0.4/ 3 /12 yr. 0.6 13.7 | 
8.7 - 
1.2 0.9 
G.S. 14.3 ? 
15.2 - 
0.4 
0.6 +0.9/ 4/12 yr. 
7.0 - 
7*4 + 
7.9 - 
0.0 
0.9 
0.3 2.2 - 
4.5** 
3.0 - 
0.4 
8.2 J M.T. 14.0 J 
14.2 - 
0.0 0.5 0.4 0.3 
0.6 +0.2/ 712 yr. 
-0.2/ 1712 yr. 
8.0 ± 
8.3** 
0.3 7.5 ± 
8.3** 
0.5 2.7 t 0.3 
14.0** 
0.0/ 1/12 yr. 
14.3** +0.3/ 1712 yr. 8.0** 8.3** 2.5** 
+0.1/ 2/12 yr. 
* all measurements in centimeters - 1 S.D. 
+ performed during same hospital admission; the first examination is 
an intravenous pyelogram, the second a tomogram 
** read by only one radiologist 
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RESULTS OF SERIAL PYELOGRAPHY IN ELEVEN PATIENTS AS READ BY SIX 
STAFF RADIOLOGISTS AT THE YALE-NEW HAVEN HOSPITAL: 
PRECISION OF VARIABILITY*** 
Calyceal Parenchymal 
Length Width Length Width 
Right kidney + 1.1 ± °*7 + 0.9 + 0.7 
Left kidney + 1.1 + 0.7 ± 1>1 + 0.7 
*** measurements in centimeters 
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FIGURE 1= COMPARATIVE MEASUREMENTS OF KIDNEY LENGTH 
0 o 
SIX STAFF RADIOLOGISTS 
LEGEND 
-range of variability 
• LEFT KIDNEY 
• RIGHT KIDNEY 
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FIGURE 2: COMPARATIVE MEASUREMENTS OF KIDNEY 
WIDTH 
SIX STAFF RADIOLOGISTS 
LEGEND 
- - RANGE OF VARIABILITY 
• LEFT KIDNEY 
° RIGHT KIDNEY 
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FIGURE 3: COMPARATIVE MEASURENTS OF RENAL 
PARENCHYMAL WIDTH 
legend 
— range of Variability 
• LEFT KIDNEY 
° RIGHT KIDNEY 
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FIGURE 4: COMPARATIVE MEASUREMENT OF RENAL 
CALYCEAL LENGTH 
SIX STAFF RADIOLOGISTS 
LEGEND 
-range of variability 
• LEFT KIDNEY 
® RIGHT KIDNEY 

APPENDIX B 
INDICATIONS FOR INVESTIGATION IN SEVENTY FIVE PATIENTS WITH NORMAL 
INTRAVENOUS PYELOGRAMS 
Indication on Radiology Requisition Number of Cases 
Hypertension 
Recurrent urinary tract infection 
Hematuria 
Flank or back pain 
Benign hypertrophy of the prostata 
Ureteral colic 
Fever of unknown origin 
Diabetes Mellitus 
Carcinoma of the cervix 
Diverticulosis 
Pancreatitis 
Crohn's disease 
Tuberculosis 
Carcinoma of the breast 
Mycosis fungoides 
Kidney donor 
Testicular pain 
17 
13 
8 
7 
5 
4 
4 
4 
3 
2 
2 
1 
1 
1 
1 
1 
1 
CALYCEAL LENGTH IN NORMAL KIDNEYS * 
Right kidney 
Men 
7.3 - 0.80 
Women 
6.8 - 0.84 
Total 
7.1 - 0.87 
Left kidney 7.4 - 0.86 7.0 - 0.84 7.2 - 0.87 
* all measurements in cm. + 1 S. D. 
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